Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

OBJECTIVE--To examine the relation between the use of aspirin and non-steroidal anti-inflammatory drugs and the presence of asymptomatic colorectal adenomas. DESIGN--Case-control study of subjects participating in a randomised controlled trial of faecal occult blood screening for colorectal cancer. Data on analgesics and other drugs were obtained from a questionnaire which was mainly concerned with diet and was administered by an interviewer. SETTING--Nottingham. SUBJECTS--147 patients with positive results in faecal occult blood tests who were found to have colorectal adenomas (cases), 153 age and sex matched control subjects with negative results in such tests (negative controls), and 176 control subjects with positive results in the tests who were found not to have colorectal adenomas (positive controls). MAIN OUTCOME MEASURES--Relative risk of developing colorectal adenomas according to frequency and duration of use of analgesics. RESULTS--Cases reported taking less aspirin and non-steroidal anti-inflammatory drugs than the negative controls, with the estimated relative risk for any use being 0.49 (95% confidence interval 0.3 to 0.8). The inverse association was less strong when cases were compared with the positive controls (0.66 (0.4 to 1.1)). The association was specific for aspirin and non-steroidal anti-inflammatory drugs there being no association with paracetamol or other drugs. Prescribed use of non-steroidal anti-inflammatory drugs for longer than five years was associated with the lowest risk (0.21 (0.1 to 0.8)), although the numbers reporting prolonged prescribed use were small. CONCLUSIONS--These findings support the hypothesis that aspirin and non-steroidal anti-inflammatory drug use protects against the development of colorectal neoplasia.

[1]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[2]  S. Moss,et al.  RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER Results for First 107 349 Subjects , 1989, The Lancet.

[3]  C. Tzourio,et al.  Migraine and risk of ischaemic stroke: a case-control study. , 1993, BMJ.

[4]  S. Shapiro,et al.  A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.

[5]  J. Wong,et al.  Intrathoracic gastric bypass for carcinoma of oesophagus found unresectable at exploration , 1982, British Journal of Surgery.

[6]  J. Hardcastle,et al.  Bleeding patterns in colorectal cancer: The effect of aspirin and the implications for faecal occult blood testing , 1982, The British journal of surgery.

[7]  T. Narisawa,et al.  Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. , 1983, Carcinogenesis.

[8]  L. Turnberg,et al.  REAPPRAISAL OF THE EFFECTS OF ASPIRIN ON THE STOMACH , 1980, The Lancet.

[9]  J. B. Simon.  Colonic polyps, occult blood, and chance. , 1990, JAMA.

[10]  Morris Pollard,et al.  The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. , 1983, Cancer letters.

[11]  Morris Pollard,et al.  Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. , 1980, Cancer treatment reports.

[12]  T. Kudo,et al.  Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. , 1981, Cancer research.

[13]  D. Ransohoff,et al.  Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity. , 1990, JAMA.

[14]  B. Henderson,et al.  Aspirin use and incidence of large-bowel cancer in a California retirement community. , 1991, Journal of the National Cancer Institute.

[15]  G. Pye,et al.  Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer. , 1987, British medical journal.

[16]  F. DeRubertis,et al.  16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin. , 1985, Gastroenterology.

[17]  J. Hardcastle,et al.  Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. , 1990, Gut.

[18]  Morris Pollard,et al.  Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. , 1983, Journal of the National Cancer Institute.

[19]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[20]  L F Watson,et al.  Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.

[21]  W. Waddell,et al.  Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.

[22]  R. G. Norfleet.  1,300 mg of aspirin daily does not cause positive fecal hemoccult tests. , 1983, Journal of Clinical Gastroenterology.

[23]  Jayashree,et al.  Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. , 1990, Cancer research.

[24]  Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. , 1993, British Journal of Cancer.

[25]  Morris Pollard,et al.  Treatment of Chemically-Induced Intestinal Cancers with Indomethacin 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  G. Kelloff,et al.  Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. , 1987, Cancer research.

[27]  N. Armitage,et al.  A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. , 1985, British Journal of Cancer.

[28]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[29]  U. Metzger,et al.  Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer , 1984, Diseases of the colon and rectum.

[30]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.